Mounjaro (tirzepatide) and Wegovy (semaglutide) are two leading weight loss injections available in the UK. Both are GLP-1 receptor agonists, but Mounjaro is unique because it targets <strong data-start="210" data-end="240">two hormones&mdash;GLP-1 and GIP, offering potentially greater weight reduction. Clinical studies suggest Mounjaro users may achieve <strong data-start="341" data-end="371">up to 20% body weight loss, compared to around <strong data-start="392" data-end="411">15% with Wegovy. Wegovy, however, has been available longer and is more widely prescribed, especially through the NHS. Side effects for both include nausea, vomiting, and digestive issues. Ultimately, the choice between Mounjaro vs Wegovy depends on individual health needs, eligibility, and doctor recommendations.

Great explanation throughout the article. The flow, the examples, and the clarity were perfect. I&rsquo;m definitely sharing this with others who might benefit. 윈가라오케

I learned a lot from this post. The explanations were detailed yet easy to follow. You&rsquo;ve clearly done your research, and it shows in the quality of your writing. Thanks for sharing this knowledge. 강남가라오케